IL160195D0 - Oral dosage form comprising a therapeutic agent and an adverse-effect agent - Google Patents

Oral dosage form comprising a therapeutic agent and an adverse-effect agent

Info

Publication number
IL160195D0
IL160195D0 IL16019502A IL16019502A IL160195D0 IL 160195 D0 IL160195 D0 IL 160195D0 IL 16019502 A IL16019502 A IL 16019502A IL 16019502 A IL16019502 A IL 16019502A IL 160195 D0 IL160195 D0 IL 160195D0
Authority
IL
Israel
Prior art keywords
agent
adverse
dosage form
oral dosage
effect
Prior art date
Application number
IL16019502A
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US30979101P priority Critical
Priority to US10/208,817 priority patent/US20030044458A1/en
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Priority to PCT/US2002/024889 priority patent/WO2003013538A1/en
Publication of IL160195D0 publication Critical patent/IL160195D0/en

Links

IL16019502A 2001-08-06 2002-08-05 Oral dosage form comprising a therapeutic agent and an adverse-effect agent IL160195D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US30979101P true 2001-08-06 2001-08-06
US10/208,817 US20030044458A1 (en) 2001-08-06 2002-08-01 Oral dosage form comprising a therapeutic agent and an adverse-effect agent
PCT/US2002/024889 WO2003013538A1 (en) 2001-08-06 2002-08-05 Oral dosage form comprising a therapeutic agent and an adverse-effect agent

Publications (1)

Publication Number Publication Date
IL160195D0 true IL160195D0 (en) 2004-07-25

Family

ID=26903530

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16019502A IL160195D0 (en) 2001-08-06 2002-08-05 Oral dosage form comprising a therapeutic agent and an adverse-effect agent

Country Status (2)

Country Link
DE (1) DE60234604D1 (en)
IL (1) IL160195D0 (en)

Also Published As

Publication number Publication date
DE60234604D1 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
TWI322015B (en) Pharmaceutical formulation
GB2372542B (en) Dosage counting devices
GB2372543B (en) Dosage counting devices
GB2364916B (en) Drug delivery device
GB2372541B (en) Dosage counting devices
AU5326501A (en) Oral treatment systems
PT1296974E (en) 2-cyanopyrrolidine derivatives and their use as medicaments
PT1913939T (en) Formulations for use in inhaler devices
AU2001270113A1 (en) Medicament inhaler
AU6488701A (en) Drug delivery device
GB0319041D0 (en) Pharmaceutical Formulations
MXPA01008142A (en) Amide compounds and medicinal use thereof.
GB0011053D0 (en) Medical device and use thereof
AU4725001A (en) Nasal oral respiratory interface
AU7544501A (en) 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
HRP20040559A2 (en) Metered dose inhaler
AU8356301A (en) Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
PL204141B1 (en) Solid dosage form of someticone for oral administration
HRP20040027A2 (en) 1-phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
GB0112834D0 (en) Medicaments
HK1070285A1 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylate
GB0118238D0 (en) Medicaments
GB0003397D0 (en) Therapeutic agents
GB0012671D0 (en) Therapeutic agents
GB0112836D0 (en) Medicaments